Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 3
2014 1
2016 7
2017 4
2018 3
2019 7
2020 3
2021 4
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma.
Chiavelli C, Prapa M, Rovesti G, Silingardi M, Neri G, Pugliese G, Trudu L, Dall'Ora M, Golinelli G, Grisendi G, Vinet J, Bestagno M, Spano C, Papapietro RV, Depenni R, Di Emidio K, Pasetto A, Nascimento Silva D, Feletti A, Berlucchi S, Iaccarino C, Pavesi G, Dominici M. Chiavelli C, et al. Among authors: pasetto a. NPJ Precis Oncol. 2024 Feb 1;8(1):26. doi: 10.1038/s41698-024-00506-z. NPJ Precis Oncol. 2024. PMID: 38302615 Free PMC article.
Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease.
Yan J, Bangalore CR, Nikouyan N, Appelberg S, Silva DN, Yao H, Pasetto A, Weber F, Weber S, Larsson O, Höglund U, Bogdanovic G, Grabbe M, Aleman S, Szekely L, Szakos A, Tuvesson O, Gidlund EK, Cadossi M, Salati S, Tegel H, Hober S, Frelin L, Mirazimi A, Ahlén G, Sällberg M. Yan J, et al. Among authors: pasetto a. Mol Ther. 2024 Feb 7;32(2):540-555. doi: 10.1016/j.ymthe.2024.01.007. Epub 2024 Jan 11. Mol Ther. 2024. PMID: 38213030 Free article.
Editorial: Personalized immunotherapy for cancer.
Pasetto A, Lu YC. Pasetto A, et al. Front Oncol. 2023 Mar 7;13:1171907. doi: 10.3389/fonc.2023.1171907. eCollection 2023. Front Oncol. 2023. PMID: 36959783 Free PMC article. No abstract available.
T-Cell Repertoire Characterization.
Pasetto A, Buggert M. Pasetto A, et al. Methods Mol Biol. 2022;2574:209-219. doi: 10.1007/978-1-0716-2712-9_9. Methods Mol Biol. 2022. PMID: 36087203
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
Burm R, Maravelia P, Ahlen G, Ciesek S, Caro Perez N, Pasetto A, Urban S, Van Houtte F, Verhoye L, Wedemeyer H, Johansson M, Frelin L, Sällberg M, Meuleman P. Burm R, et al. Among authors: pasetto a. Gut. 2023 Jun;72(6):1186-1195. doi: 10.1136/gutjnl-2022-327216. Epub 2022 Aug 17. Gut. 2023. PMID: 35977815 Free PMC article.
Cancer genes disfavoring T cell immunity identified via integrated systems approach.
Kishton RJ, Patel SJ, Decker AE, Vodnala SK, Cam M, Yamamoto TN, Patel Y, Sukumar M, Yu Z, Ji M, Henning AN, Gurusamy D, Palmer DC, Stefanescu RA, Girvin AT, Lo W, Pasetto A, Malekzadeh P, Deniger DC, Wood KC, Sanjana NE, Restifo NP. Kishton RJ, et al. Among authors: pasetto a. Cell Rep. 2022 Aug 2;40(5):111153. doi: 10.1016/j.celrep.2022.111153. Cell Rep. 2022. PMID: 35926468 Free PMC article.
Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products.
Silva DN, Chrobok M, Rovesti G, Healy K, Wagner AK, Maravelia P, Gatto F, Mazza M, Mazzotti L, Lohmann V, Sällberg Chen M, Sällberg M, Buggert M, Pasetto A. Silva DN, et al. Among authors: pasetto a. Front Immunol. 2022 Jun 16;13:896242. doi: 10.3389/fimmu.2022.896242. eCollection 2022. Front Immunol. 2022. PMID: 35784320 Free PMC article.
39 results